Skip to Content

CFZ 300 (Invokana 300 mg)

Generic Name: canagliflozin

Pill with imprint CFZ 300 is White, Capsule-shape and has been identified as Invokana 300 mg. It is supplied by Janssen Pharmaceuticals, Inc..

Invokana is used in the treatment of diabetes, type 2 and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Invokana 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for CFZ 300

Invokana

Generic Name:
canagliflozin
Imprint:
CFZ 300
Strength:
300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
SGLT-2 inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC):
50458-0141

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide